NASDAQ
NSPR

InspireMD Inc

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

InspireMD Inc Stock Price

Vitals

Today's Low:
$3.5125
Today's High:
$3.77
Open Price:
$3.589
52W Low:
$0.81
52W High:
$3.77
Prev. Close:
$3.57
Volume:
52281

Company Statistics

Market Cap.:
$76.78 million
Book Value:
2.209
Revenue TTM:
$5.35 million
Operating Margin TTM:
-360%
Gross Profit TTM:
$1.12 million
Profit Margin:
0%
Return on Assets TTM:
-27.84%
Return on Equity TTM:
-51.57%

Company Profile

InspireMD Inc had its IPO on 2011-04-12 under the ticker symbol NSPR.

The company operates in the Healthcare sector and Medical Devices industry. InspireMD Inc has a staff strength of 55 employees.

Stock update

Shares of InspireMD Inc opened at $3.59 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $3.51 - $3.77, and closed at $3.51.

This is a -1.61% slip from the previous day's closing price.

A total volume of 52,281 shares were traded at the close of the day’s session.

In the last one week, shares of InspireMD Inc have increased by +1.81%.

InspireMD Inc's Key Ratios

InspireMD Inc has a market cap of $76.78 million, indicating a price to book ratio of 0.4307 and a price to sales ratio of 1.6747.

In the last 12-months InspireMD Inc’s revenue was $5.35 million with a gross profit of $1.12 million and an EBITDA of $-19025000. The EBITDA ratio measures InspireMD Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, InspireMD Inc’s operating margin was -360% while its return on assets stood at -27.84% with a return of equity of -51.57%.

In Q2, InspireMD Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 7.7%.

InspireMD Inc’s PE and PEG Ratio

Forward PE
11.6959
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-1.83 per share while it has a forward price to earnings multiple of 11.6959 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into InspireMD Inc’s profitability.

InspireMD Inc stock is trading at a EV to sales ratio of 0.167 and a EV to EBITDA ratio of 0.5674. Its price to sales ratio in the trailing 12-months stood at 1.6747.

InspireMD Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$53.64 million
Total Liabilities
$4.83 million
Operating Cash Flow
$0
Capital Expenditure
$45000
Dividend Payout Ratio
0%

InspireMD Inc ended 2024 with $53.64 million in total assets and $0 in total liabilities. Its intangible assets were valued at $53.64 million while shareholder equity stood at $46.81 million.

InspireMD Inc ended 2024 with $0 in deferred long-term liabilities, $4.83 million in other current liabilities, 2000.00 in common stock, $-210918000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $11.55 million and cash and short-term investments were $46.99 million. The company’s total short-term debt was $418,000 while long-term debt stood at $0.

InspireMD Inc’s total current assets stands at $50.52 million while long-term investments were $0 and short-term investments were $35.45 million. Its net receivables were $1.78 million compared to accounts payable of $768000.00 and inventory worth $1.69 million.

In 2024, InspireMD Inc's operating cash flow was $0 while its capital expenditure stood at $45000.

Comparatively, InspireMD Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$3.51
52-Week High
$3.77
52-Week Low
$0.81
Analyst Target Price
$4.35

InspireMD Inc stock is currently trading at $3.51 per share. It touched a 52-week high of $3.77 and a 52-week low of $3.77. Analysts tracking the stock have a 12-month average target price of $4.35.

Its 50-day moving average was $3.16 and 200-day moving average was $1.79 The short ratio stood at 2.45 indicating a short percent outstanding of 0%.

Around 1233.6% of the company’s stock are held by insiders while 1801.9% are held by institutions.

Frequently Asked Questions About InspireMD Inc

The stock symbol (also called stock or share ticker) of InspireMD Inc is NSPR

The IPO of InspireMD Inc took place on 2011-04-12

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$0.35
-0.02
-5.74%
$1.55
0
0%
$63.82
-3.06
-4.58%
Aviva PLC ADR (AVVIY)
$9.55
0.05
+0.53%
$20.85
0.02
+0.1%
$1730.85
-22
-1.26%
$426.1
-14.85
-3.37%
Fairchem Organics Ltd (FAIRCHEMOR)
$1167.4
-65.1
-5.28%
$185.3
-3.7
-1.96%
$128.06
1.32
+1.04%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Delivery System, a mesh-covered self-expanding carotid stent; SwitchGuard, a non-invasive transcarotid artery revascularization device; and NGuard EPS for treating acute stroke with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Address

4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832